Männedorf, Switzerland, October 30, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Ralf Griebel has been appointed a member of the Management Board and Head of the Partnering Business division. He will assume his new position at Tecan no later than May 1, 2020. Until then, Achim von Leoprechting, CEO of Tecan,... Read more
Männedorf, Switzerland, August 30, 2019 – Tecan Group Ltd. (SIX Swiss Exchange: TECN) announced today that the Board of Directors has appointed Tania Micki to succeed Dr. Rudolf Eugster as Chief Financial Officer (CFO) of Tecan and a member of the Management Board. Rudolf Eugster will be leaving the Company following the annual financial statements 2019... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed three additional patent infringement suits relating to BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents. The first complaint was filed against Complete Genomics, Inc. and other BGI entities in the United States District Court for the Northern District of California... Read more
Including a first-of-its-kind ultra-micro balance, the METTLER TOLEDO’s XPR line presents a welcome combination of usability and accuracy. This combination is critical in industries such as pharmaceuticals where sample sizes are small and productivity must be maintained. Greifensee, Switzerland—December 2, 2018—Notable in this line is XPR6UD5, the first ultra-micro balance on the market. It offers a... Read more
Torrance, Calif. (September 5, 2017) – Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announced today that it will begin to directly serve customers in Switzerland, effective September 1, 2017. For over 26 years, Phenomenex has partnered with local distributer, Brechbühler AG, in pursuing the common... Read more
Agreement centered on next-generation sequencing oncology research and companion diagnostic development programs CARLSBAD, Calif., April 18, 2017 /PRNewswire/ — Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center... Read more